E. Meijers-Heijboer

发表

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy.

J. Klijn, C. Seynaeve, A. V. D. van den Ouweland, 2004, European journal of cancer.

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

C. Seynaeve, J. Klijn, E. Meijers-Heijboer, 2000, British Journal of Cancer.

One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery)

J. Klijn, C. Seynaeve, C. Brekelmans, 2002, Breast Cancer Research and Treatment.

Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing

J. Klijn, C. Seynaeve, M. Niermeijer, 2003, American journal of medical genetics. Part A.

Presymptomatic testing for BRCA1 andBRCA2: how distressing are the pre-test weeks?

P. Devilee, A. Wagner, H. Duivenvoorden, 1999, Journal of medical genetics.

Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.

P. Devilee, A. Wagner, H. Duivenvoorden, 1999, Journal of medical genetics.

Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation.

C. Seynaeve, A. Eggermont, J. Klijn, 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

What do women really want to know? Motives for attending familial breast cancer clinics

W. Otten, J. Kievit, C. V. van Asperen, 2002, Journal of medical genetics.

Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree

A. Zwinderman, R. Hofstra, A. Wagner, 2001, Journal of medical genetics.

Molecular analysis of aniridia patients for deletions involving the Wilms' tumor gene

S. Schneider, A. Blankenagel, B. Royer-Pokora, 1994, Human Genetics.

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary

J. C. Houwelingen, L. J. Veer, S. Verhoef, 2005, Journal of Medical Genetics.

Attitudes towards termination of pregnancy in subjects who underwent presymptomatic testing for theBRCA1/BRCA2 gene mutation in The Netherlands

J. Klijn, M. Niermeijer, R. W. Trijsburg, 2000, Journal of medical genetics.

Males at–risk for the BRCA1‐1ene, the psychological impact

P. Devilee, A. Tibben, M. Niermeijer, 1996 .

BRCA1 in the family: a case description of the psychological implications.

P. Devilee, J. Oosterwijk, A. Tibben, 1997, American journal of medical genetics.

Accuracy of BRCA1 and BRCA2 Founder Mutation Analysis in Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue

K. Offit, J. Boyd, T. Kirchhoff, 2006, Familial Cancer.

Carrier detection of Batten disease (juvenile neuronal ceroid-lipofuscinosis).

J. G. Post, M. Breuning, N. de Vos, 1995, American journal of medical genetics.

Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.

J. Klijn, C. Seynaeve, A. V. D. van den Ouweland, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect on a Dutch family of predictive DNA-testing for hereditary breast and ovarian cancer

P. Devilee, A. Tibben, J. Klijn, 1994, The Lancet.

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary

J. C. Houwelingen, L. J. Veer, S. Verhoef, 2005, Journal of Medical Genetics.

Characterisation of six large deletions in TSC 2 identified using long range PCR suggests diverse mechanisms including Alu mediated recombination

E. Meijers-Heijboer, 2000 .

Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing

P. Devilee, A. Wagner, H. Duivenvoorden, 2001, European Journal of Human Genetics.

Psychological impact of receiving a BRCA1/BRCA2 test result.

J. Klijn, A. V. D. van den Ouweland, A. Wagner, 2001, American journal of medical genetics.

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

P. Devilee, C. Seynaeve, A. Wagner, 2000, The Lancet.

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

J. Klijn, P. Devilee, C. Seynaeve, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1

J. Klijn, P. Devilee, A. Ouweland, 1998, The Lancet.

Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients.

E. Berns, C. Seynaeve, C. Brekelmans, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16.

A. Cats, R. Fodde, R. Kolodner, 1996, American journal of human genetics.

Linkage analysis with chromosome 15q11-13 markers shows genomic imprinting in familial Angelman syndrome.

H. Smeets, M. Nelen, H. Brunner, 1992, Journal of medical genetics.

Psychological factors associated with the intention to choose for risk-reducing mastectomy in family cancer clinic attendees.

C. Asperen, C. V. van Asperen, J. Oosterwijk, 2016, Breast.

Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.

Rotterdam, J. Passchier, H. Duivenvoorden, 1998, Journal of medical genetics.

Presymptomatic testing for BRCA 1 and BRCA 2 : how distressing are the pre-test weeks ?

P. Devilee, A. Wagner, C. Cornelisse, 1999 .

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

V. Pankratz, F. Couch, O. Olopade, 2010, Cancer research.